Sangamo Therapeutics
SGMO
#10418
Rank
โ‚ฌ26.85 M
Marketcap
0,06482ย โ‚ฌ
Share price
0.00%
Change (1 day)
-84.47%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -โ‚ฌ94.3 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ34.55 Million. In 2025 the company made an earning of -โ‚ฌ94.62 Million a decrease over its 2024 earnings that were of -โ‚ฌ86.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ94.3 Million-0.33%
2025 -โ‚ฌ94.62 Million9.71%
2024 -โ‚ฌ86.25 Million-17.27%
2023 -โ‚ฌ0.11 Billion-40.88%
2022 -โ‚ฌ0.18 Billion9.79%
2021 -โ‚ฌ0.17 Billion41.52%
2020 -โ‚ฌ0.12 Billion23.17%
2019 -โ‚ฌ92.14 Million36.33%
2018 -โ‚ฌ67.59 Million36.89%
2017 -โ‚ฌ49.38 Million-22.32%
2016 -โ‚ฌ63.57 Million54.86%
2015 -โ‚ฌ41.05 Million75.62%
2014 -โ‚ฌ23.38 Million0.13%
2013 -โ‚ฌ23.35 Million
2011 -โ‚ฌ31.38 Million43.66%
2010 -โ‚ฌ21.85 Million28.52%
2009 -โ‚ฌ17 Million-23.55%
2008 -โ‚ฌ22.24 Million2.45%
2007 -โ‚ฌ21.7 Million19.5%
2006 -โ‚ฌ18.16 Million50.78%
2005 -โ‚ฌ12.05 Million75%
2004 -โ‚ฌ6.89 Million-33.25%
2003 -โ‚ฌ10.31 Million-62.27%
2002 -โ‚ฌ27.33 Million102.82%
2001 -โ‚ฌ13.48 Million23.21%
2000 -โ‚ฌ10.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.75 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.96 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.42 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚ฌ2.22 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ9.39 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.52 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ0.76 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.33 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA